Medical guideline

首页肿瘤学指南检索结果

检索结果

按发表年份

共搜索到23条与Malignancy有关的结果

Cancer in People with HIV

2021年发布于 National Comprehensive Cancer Network 卷第期 所属人体系统：其他 | 癌症患者其他类问题管理

National Comprehensive Cancer Network

Cancer HIV AIDS-Defining Malignancy Non-AIDS-Defining Malignancy
指南简介 原文链接
Preexisting Melanoma and Hematological Malignancies, Prognosis, and Timing to Solid Organ Transplantation: a Consensus Expert Opinion Statement

2021年发布于 American Journal of Transplantation 21卷第2期 所属人体系统：循环 | 血液肿瘤

American Society of Transplantation

Cancer/malignancy/neoplasia Clinical Research/practice Editorial/personal Viewpoint Organ Transplantation in General Patient Safety Recipient Selection
指南简介 原文链接
2021 Update of the AGIHO Guideline on Evidence-based Management of COVID-19 in Patients with Cancer Regarding Diagnostics, Viral Shedding, Vaccination and Therapy

2021年发布于 European Journal of Cancer 147卷第期 所属人体系统：其他 | COVID-19大流行癌症患者相关指导建议

Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology

COVID-19 Cancer Guideline Haematological Malignancy SARS-CoV-2 Vaccination.
指南简介 原文链接
Pretransplant Solid Organ Malignancy and Organ Transplant Candidacy: a Consensus Expert Opinion Statement

2021年发布于 American Journal of Transplantation 21卷第2期 所属人体系统：其他 | 实体瘤

无

Cancer / Malignancy / Neoplasia Clinical Research / Practice Editorial / Personal Viewpoint Organ Transplantation in General Patient Safety Recipient Selection.
指南简介 原文链接
Brazilian Group of Gastrointestinal Tumours' Consensus Guidelines for the Management of Oesophageal Cancer

2021年发布于 ecancermedicalscience 127卷第4期 所属人体系统：消化 | 胃肠道肿瘤

Brazilian Group of Gastrointestinal Tumours'

Adult aplastic Anemia article cancer Patient cord Blood Stem Cell Transplantation disease Free Survival drug Therapy graft Recipient hematologic Malignancy human patient Selection practice Guideline surgery thymocyte Antibody
指南简介 原文链接
Management of Salivary Gland Malignancy: ASCO Guideline

2021年发布于 American Society of Clinical Oncology 卷第期 所属人体系统：消化 | 唾液腺癌

American Society of Clinical Oncology

Salivary Gland Malignancy Management diagnosis preoperative Evaluation therapeutic Procedures treatment Options
指南简介 原文链接
2020 Imaging Guidelines for Thyroid Nodules and Differentiated Thyroid Cancer: Korean Society of Thyroid Radiology

2021年发布于 Korean journal of radiology 22卷第5期 所属人体系统：内分泌 | 甲状腺肿瘤

Korean Society of Thyroid Radiology

Guideline Thyroid Thyroid Malignancy Thyroid Nodule Thyroid Recurrent Cancers.
指南简介 原文链接
An International Delphi Consensus Building Approach to Patient Assessment and Use of Immunoglobulin Treatment for Secondary Immune Deficiencies in Hematological Malignancy

2020年发布于 HemaSphere 4卷第 Supplement 1期 所属人体系统：循环 | 白血病

无

Hematological Malignancy Secondary Immune Deficiencies Immunoglobulin Treatment Consensus
指南简介 原文链接
Chinese Expert Consensus Workshop Report: Guideline for Permanent Iodine-125 Seeds Implantation of Primary and Metastatic Lung Tumors (2020 Edition)

2020年发布于 Journal of Cancer Research and Therapeutics 16卷第7期 所属人体系统：呼吸 | 肺癌

Interstitial Brachytherapy Society Committee of Minimally Invasive Therapy in Oncology Chinese Anti-Cancer Association

Guidelines Implantation Iodine-125 Lung Malignancy.
指南简介 原文链接
Secondary Immune Deficiencies in Hematological Malignancy: Developing International Consensus on Patient Assessment and Selection for Immunoglobulin Replacement Therapy (IgRT)

2020年发布于 Journal of Clinical Immunology 40卷第SUPPL 1期 所属人体系统：循环 | 血液肿瘤

无

Hematological Malignancy Secondary Immune Deficiencies Immunoglobulin Replacement Therapy Consensus
指南简介 原文链接
Evidence-based Management of COVID-19 in Cancer Patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)

2020年发布于 European Journal of Cancer 140卷第期 所属人体系统：其他 | COVID-19大流行癌症患者相关指导建议

Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)

COVID-19 Cancer Coronavirus Guideline Haematological Malignancy SARS-CoV-2.
指南简介 原文链接
Penile Cancer: a Brazilian Consensus Statement for Low- and Middle-income Countries

2020年发布于 Journal of Cancer Research and Clinical Oncology 146卷第12期 所属人体系统：生殖 | 阴茎癌

无

Cancer Consensus HPV Cancer-related Penile Cancer Urologic Malignancy
指南简介 原文链接
Chinese Expert Consensus Workshop Report: Guideline for Permanent Iodine-125 Seed Implantation of Primary and Metastatic Lung Tumors

2019年发布于 Thoracic Cancer 10卷第2期 所属人体系统：呼吸 | 肺癌

Chinese Anti-Cancer Association

Guideline Implantation Iodine-125 Lung Malignancy.
指南简介 原文链接
Diagnostic Value of Imaging (ultrasonography, Doppler, CT, MR, PET-CT) for the Diagnosis of a Suspicious Ovarian Mass and Staging of Ovarian, Tubal Or Primary Peritoneal Cancer: Article Drafted from the French Guidelines in Oncology Entitled `Initial Man

2019年发布于 Gynecol Obstet Fertil Senol 47卷第2期 所属人体系统：生殖 | 输卵管癌

FRANCOGYN (Groupe Français De Recherche En Chirurgie Oncologique Et Gynécologique) Au CNGOF (Collège National Des Gynécologues Obstétriciens Français) À La SFOG (Société Française D’oncologie Gynécologique Et Au Groupe GINECO-ARCAGY (Groupe D’investigateurs Nationaux Pour L’étude Des Cancers Ovariens Et Du Sein – Association De Recherche Sur Les Cancers Dont Gynécologiques) Et Sont Labellisées Par L’INCa (Institut National Du Cancer).

Transvaginal Ultrasound Is the First-line Examination Allowing Characterizing 80 to 90% of Adnexal Masses (LP1). If Performed by an Expert a Subjective Analysis Is Optimal. If Performed by a Non-expert Combining the Use of Simple Rules with Subjective Analysis Can Achieve the Diagnostic Performance of an Expert (LP1). Whichever the Chosen Model (subjective Analysis by an Expert Or Combination of the Simple Rules with a Subjective Analysis by a Non-expert) a Second-line Examination Will Have to Be Proposed in the Complex Or Indeterminate Cases (about 20% of the Masses) (grade A). the Best-performing Second-line Test for Characterization Is Pelvic MRI (LP1). If Read by an Expert a Pathological Hypothesis Can Or Should Be Suggested (grade D). in Case of Non-expert Reading the Use of the ADNEXMR Score Allows a Reliable Assessment of the Positive Predictive Value of Malignancy to Guide the Patient Towards the Best Management (gradeC). for Preoperative Assessment and Evaluation of Resectability of Ovarian Fallopian Tube Or Primary Peritoneal Cancer It Is Recommended to Perform a Chest Abdomen and Pelvis CT with Contrast Agent Injection (LP2 Grade B). in the Event of a Contraindication to the Injection of Iodinated Contrast Agent (severe Renal Insufficiency GFR <30mL/min) an Abdomen and Pelvis MRI Completed with a Non-injected Chest CT May Be Proposed (LP3 Grade C). by Analogy the Same Examinations Are Recommended to Evaluate the Disease after Neo-adjuvant Chemotherapy (LP3 Recommendation Grade C). Further Studies Will Be Required to Determine Whether PET-CT Provides Better Lymph Node Assessment Before Retroperitoneal and Pelvic Lymphadenectomy. PET-CT May Be Used to Eliminate Lymph Node Involvement in the Absence of Suspicious Lymph Nodes on Morphological Examination (LP3 Grade C). the Report Should Specify the Localizations Leading to a Risk of Incomplete Cytoreductive Surgery and Lesions Outside the Field Explored During Surgery.
指南简介 原文链接
Diagnostic Value of Imaging (ultrasonography, Doppler, CT, MR, PET-CT) for the Diagnosis of a Suspicious Ovarian Mass and Staging of Ovarian, Tubal Or Primary Peritoneal Cancer: Article Drafted from the French Guidelines in Oncology Entitled `Initial Man

2019年发布于 Gynecol Obstet Fertil Senol 47卷第2期 所属人体系统：生殖 | 卵巢肿瘤

FRANCOGYN (Groupe Français De Recherche En Chirurgie Oncologique Et Gynécologique) Au CNGOF (Collège National Des Gynécologues Obstétriciens Français) À La SFOG (Société Française D’oncologie Gynécologique Et Au Groupe GINECO-ARCAGY (Groupe D’investigateurs Nationaux Pour L’étude Des Cancers Ovariens Et Du Sein – Association De Recherche Sur Les Cancers Dont Gynécologiques) Et Sont Labellisées Par L’INCa (Institut National Du Cancer).

Transvaginal Ultrasound Is the First-line Examination Allowing Characterizing 80 to 90% of Adnexal Masses (LP1). If Performed by an Expert a Subjective Analysis Is Optimal. If Performed by a Non-expert Combining the Use of Simple Rules with Subjective Analysis Can Achieve the Diagnostic Performance of an Expert (LP1). Whichever the Chosen Model (subjective Analysis by an Expert Or Combination of the Simple Rules with a Subjective Analysis by a Non-expert) a Second-line Examination Will Have to Be Proposed in the Complex Or Indeterminate Cases (about 20% of the Masses) (grade A). the Best-performing Second-line Test for Characterization Is Pelvic MRI (LP1). If Read by an Expert a Pathological Hypothesis Can Or Should Be Suggested (grade D). in Case of Non-expert Reading the Use of the ADNEXMR Score Allows a Reliable Assessment of the Positive Predictive Value of Malignancy to Guide the Patient Towards the Best Management (gradeC). for Preoperative Assessment and Evaluation of Resectability of Ovarian Fallopian Tube Or Primary Peritoneal Cancer It Is Recommended to Perform a Chest Abdomen and Pelvis CT with Contrast Agent Injection (LP2 Grade B). in the Event of a Contraindication to the Injection of Iodinated Contrast Agent (severe Renal Insufficiency GFR <30mL/min) an Abdomen and Pelvis MRI Completed with a Non-injected Chest CT May Be Proposed (LP3 Grade C). by Analogy the Same Examinations Are Recommended to Evaluate the Disease after Neo-adjuvant Chemotherapy (LP3 Recommendation Grade C). Further Studies Will Be Required to Determine Whether PET-CT Provides Better Lymph Node Assessment Before Retroperitoneal and Pelvic Lymphadenectomy. PET-CT May Be Used to Eliminate Lymph Node Involvement in the Absence of Suspicious Lymph Nodes on Morphological Examination (LP3 Grade C). the Report Should Specify the Localizations Leading to a Risk of Incomplete Cytoreductive Surgery and Lesions Outside the Field Explored During Surgery.
指南简介 原文链接
Initial Skin Cancer Screening for Solid Organ Transplant Recipients in the United States: Delphi Method Development of Expert Consensus Guidelines

2019年发布于 Transpl Int 32卷第12期 所属人体系统：其他 | 皮肤肿瘤

无

Delphi Method Consensus Guidelines Post-transplant Malignancy Skin Cancer Screening Solid Organ Transplant Recipients
指南简介 原文链接
Expert Panel Consensus Statement for Proper Evaluation of First Relapse in Multiple Myeloma

2019年发布于 Curr Hematol Malig Rep 14卷第3期 所属人体系统：循环 | 骨髓瘤

无

Aggressive Myeloma Management of Relapsed Myeloma Multiple Myeloma Refractory Plasma Cell Malignancy Guideline
指南简介 原文链接
Diagnostic Value of Imaging (ultrasonography, Doppler, CT, MR, PET-CT) for the Diagnosis of a Suspicious Ovarian Mass and Staging of Ovarian, Tubal Or Primary Peritoneal Cancer: Article Drafted from the French Guidelines in Oncology Entitled `Initial Man

2019年发布于 Gynecol Obstet Fertil Senol 47卷第2期 所属人体系统：其他 | 腹膜肿瘤

FRANCOGYN (Groupe Français De Recherche En Chirurgie Oncologique Et Gynécologique) Au CNGOF (Collège National Des Gynécologues Obstétriciens Français) À La SFOG (Société Française D’oncologie Gynécologique Et Au Groupe GINECO-ARCAGY (Groupe D’investigateurs Nationaux Pour L’étude Des Cancers Ovariens Et Du Sein – Association De Recherche Sur Les Cancers Dont Gynécologiques) Et Sont Labellisées Par L’INCa (Institut National Du Cancer).

Transvaginal Ultrasound Is the First-line Examination Allowing Characterizing 80 to 90% of Adnexal Masses (LP1). If Performed by an Expert a Subjective Analysis Is Optimal. If Performed by a Non-expert Combining the Use of Simple Rules with Subjective Analysis Can Achieve the Diagnostic Performance of an Expert (LP1). Whichever the Chosen Model (subjective Analysis by an Expert Or Combination of the Simple Rules with a Subjective Analysis by a Non-expert) a Second-line Examination Will Have to Be Proposed in the Complex Or Indeterminate Cases (about 20% of the Masses) (grade A). the Best-performing Second-line Test for Characterization Is Pelvic MRI (LP1). If Read by an Expert a Pathological Hypothesis Can Or Should Be Suggested (grade D). in Case of Non-expert Reading the Use of the ADNEXMR Score Allows a Reliable Assessment of the Positive Predictive Value of Malignancy to Guide the Patient Towards the Best Management (gradeC). for Preoperative Assessment and Evaluation of Resectability of Ovarian Fallopian Tube Or Primary Peritoneal Cancer It Is Recommended to Perform a Chest Abdomen and Pelvis CT with Contrast Agent Injection (LP2 Grade B). in the Event of a Contraindication to the Injection of Iodinated Contrast Agent (severe Renal Insufficiency GFR <30mL/min) an Abdomen and Pelvis MRI Completed with a Non-injected Chest CT May Be Proposed (LP3 Grade C). by Analogy the Same Examinations Are Recommended to Evaluate the Disease after Neo-adjuvant Chemotherapy (LP3 Recommendation Grade C). Further Studies Will Be Required to Determine Whether PET-CT Provides Better Lymph Node Assessment Before Retroperitoneal and Pelvic Lymphadenectomy. PET-CT May Be Used to Eliminate Lymph Node Involvement in the Absence of Suspicious Lymph Nodes on Morphological Examination (LP3 Grade C). the Report Should Specify the Localizations Leading to a Risk of Incomplete Cytoreductive Surgery and Lesions Outside the Field Explored During Surgery.
指南简介 原文链接
Balancing the Benefits and Harms of Thyroid Cancer Surveillance in Survivors of Childhood, Adolescent and Young Adult Cancer: Recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration with the P

2018年发布于 Cancer Treat Rev 63:28-39卷第期 所属人体系统：内分泌 | 甲状腺肿瘤

The International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration with the PanCareSurFup Consortium

Childhood Cancer/malignancy Late/adverse Effects Surveillance Survivors Thyroid Cancer/neoplasm
指南简介 原文链接
BSH Guideline: Management of Thrombotic and Haemostatic Issues in Paediatric Malignancy

2018年发布于 Br J Haematol 180卷第4期 所属人体系统：其他 | 症状管理

British Society for Haematology

Thrombotic Haemostatic Paediatric Malignancy
指南简介 原文链接

人体系统

共搜索到23条 与Malignancy有关的结果

2021年 发布于 National Comprehensive Cancer Network 卷 第期 所属人体系统： 其他 | 癌症患者其他类问题管理

National Comprehensive Cancer Network

2021年 发布于 American Journal of Transplantation 21卷 第2期 所属人体系统： 循环 | 血液肿瘤

American Society of Transplantation

2021年 发布于 European Journal of Cancer 147卷 第期 所属人体系统： 其他 | COVID-19大流行癌症患者相关指导建议

Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology

2021年 发布于 American Journal of Transplantation 21卷 第2期 所属人体系统： 其他 | 实体瘤

无

2021年 发布于 ecancermedicalscience 127卷 第4期 所属人体系统： 消化 | 胃肠道肿瘤

Brazilian Group of Gastrointestinal Tumours'

2021年 发布于 American Society of Clinical Oncology 卷 第期 所属人体系统： 消化 | 唾液腺癌

American Society of Clinical Oncology

2021年 发布于 Korean journal of radiology 22卷 第5期 所属人体系统： 内分泌 | 甲状腺肿瘤

Korean Society of Thyroid Radiology

2020年 发布于 HemaSphere 4卷 第 Supplement 1期 所属人体系统： 循环 | 白血病

无

2020年 发布于 Journal of Cancer Research and Therapeutics 16卷 第7期 所属人体系统： 呼吸 | 肺癌

Interstitial Brachytherapy Society Committee of Minimally Invasive Therapy in Oncology Chinese Anti-Cancer Association

2020年 发布于 Journal of Clinical Immunology 40卷 第SUPPL 1期 所属人体系统： 循环 | 血液肿瘤

无

2020年 发布于 European Journal of Cancer 140卷 第期 所属人体系统： 其他 | COVID-19大流行癌症患者相关指导建议

Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)

2020年 发布于 Journal of Cancer Research and Clinical Oncology 146卷 第12期 所属人体系统： 生殖 | 阴茎癌

无

2019年 发布于 Thoracic Cancer 10卷 第2期 所属人体系统： 呼吸 | 肺癌

Chinese Anti-Cancer Association

2019年 发布于 Gynecol Obstet Fertil Senol 47卷 第2期 所属人体系统： 生殖 | 输卵管癌

2019年 发布于 Gynecol Obstet Fertil Senol 47卷 第2期 所属人体系统： 生殖 | 卵巢肿瘤

2019年 发布于 Transpl Int 32卷 第12期 所属人体系统： 其他 | 皮肤肿瘤

无

2019年 发布于 Curr Hematol Malig Rep 14卷 第3期 所属人体系统： 循环 | 骨髓瘤

无

2019年 发布于 Gynecol Obstet Fertil Senol 47卷 第2期 所属人体系统： 其他 | 腹膜肿瘤

2018年 发布于 Cancer Treat Rev 63:28-39卷 第期 所属人体系统： 内分泌 | 甲状腺肿瘤

The International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration with the PanCareSurFup Consortium

2018年 发布于 Br J Haematol 180卷 第4期 所属人体系统： 其他 | 症状管理

British Society for Haematology

共搜索到23条与Malignancy有关的结果

2021年发布于 National Comprehensive Cancer Network 卷第期 所属人体系统：其他 | 癌症患者其他类问题管理

2021年发布于 American Journal of Transplantation 21卷第2期 所属人体系统：循环 | 血液肿瘤

2021年发布于 European Journal of Cancer 147卷第期 所属人体系统：其他 | COVID-19大流行癌症患者相关指导建议

2021年发布于 American Journal of Transplantation 21卷第2期 所属人体系统：其他 | 实体瘤

2021年发布于 ecancermedicalscience 127卷第4期 所属人体系统：消化 | 胃肠道肿瘤

2021年发布于 American Society of Clinical Oncology 卷第期 所属人体系统：消化 | 唾液腺癌

2021年发布于 Korean journal of radiology 22卷第5期 所属人体系统：内分泌 | 甲状腺肿瘤

2020年发布于 HemaSphere 4卷第 Supplement 1期 所属人体系统：循环 | 白血病

2020年发布于 Journal of Cancer Research and Therapeutics 16卷第7期 所属人体系统：呼吸 | 肺癌

2020年发布于 Journal of Clinical Immunology 40卷第SUPPL 1期 所属人体系统：循环 | 血液肿瘤

2020年发布于 European Journal of Cancer 140卷第期 所属人体系统：其他 | COVID-19大流行癌症患者相关指导建议

2020年发布于 Journal of Cancer Research and Clinical Oncology 146卷第12期 所属人体系统：生殖 | 阴茎癌

2019年发布于 Thoracic Cancer 10卷第2期 所属人体系统：呼吸 | 肺癌

2019年发布于 Gynecol Obstet Fertil Senol 47卷第2期 所属人体系统：生殖 | 输卵管癌

2019年发布于 Gynecol Obstet Fertil Senol 47卷第2期 所属人体系统：生殖 | 卵巢肿瘤

2019年发布于 Transpl Int 32卷第12期 所属人体系统：其他 | 皮肤肿瘤

2019年发布于 Curr Hematol Malig Rep 14卷第3期 所属人体系统：循环 | 骨髓瘤

2019年发布于 Gynecol Obstet Fertil Senol 47卷第2期 所属人体系统：其他 | 腹膜肿瘤

2018年发布于 Cancer Treat Rev 63:28-39卷第期 所属人体系统：内分泌 | 甲状腺肿瘤

2018年发布于 Br J Haematol 180卷第4期 所属人体系统：其他 | 症状管理